Peripheral Blood Exosomal miR-184-3p in Methamphetamine Use Disorder: Biomarker Potential and CRTC1-Mediated...

Area of Science:

• Neuroscience
• Molecular Biology
• Biochemistry

Background:

• Neurobiological mechanisms of methamphetamine use disorder (MUD) are not fully understood.
• Diagnostic markers and effective treatments for MUD are limited.
• Exosomes offer potential as biomarkers for neuropsychiatric disorders.

Purpose of the Study:

• To investigate alterations in exosomal miRNA expression in MUD patients.
• To explore potential mechanisms involved in MUD pathogenesis.
• To identify potential diagnostic biomarkers for MUD.

Main Methods:

• miRNA sequencing and RT-qPCR to identify differentially expressed exosomal miRNAs.
• Receiver Operating Characteristic (ROC) analysis to evaluate diagnostic accuracy.
• Dual luciferase reporter assay to confirm miRNA-target gene interactions.

Main Results:

• Exosomal miR-184-3p and miR-4433a-5p were significantly decreased in MUD patients.
• Exosomal miR-184-3p demonstrated high diagnostic accuracy (AUCs of 0.902 and 0.823).
• miR-184-3p potentially targets CRTC1, implicating the CRTC1/CREB pathway in MUD.

Conclusions:

• Peripheral blood exosomal miR-184-3p may serve as a potential diagnostic and assessment biomarker for MUD.
• Exosomal miR-184-3p may play a role in MUD pathophysiology via CRTC1/CREB pathway regulation.
• Further research is needed to validate these findings and explore therapeutic implications.